Acorda Therapeutics
ACOR
#10368
Rank
S$1.12 M
Marketcap
$0.91
Share price
0.00%
Change (1 day)
-95.50%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -S$0.36 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are S$0.11 Billion. In 2023 the company made an earning of -S$0.37 Billion a decrease over its 2022 earnings that were of -S$7.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

2008201220162020- $0.3B- $0.2B- $0.1B$0.1B0companiesmarketcap.com

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.36 Billion-0.71%
2023 -S$0.37 Billion4848.63%
2022 -S$7.33 Million-93.25%
2021 -S$0.11 Billion2.52%
2020 -S$0.11 Billion-69.45%
2019 -S$0.35 Billion-700.62%
2018 S$57.62 M-118.02%
2017 -S$0.32 Billion805.99%
2016 -S$35.31 Million-173.88%
2015 S$47.78 M-6.58%
2014 S$51.14 M20.19%
2013 S$42.55 M18.7%
2012 S$35.85 M-26.54%
2011 S$48.8 M
2009 -S$0.12 Billion10.65%
2008 -S$0.11 Billion86.17%
2007 -S$54.1 Million68.1%
2006 -S$32.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$26.36 M-107.07%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.53 B-244.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.11 Billion-71.85%๐Ÿ‡ฉ๐Ÿ‡ช Germany
S$0.17 B-147.61%๐Ÿ‡บ๐Ÿ‡ธ USA